Remedium Lifecare Stock Screener | Share Price & Fundamental Analysis

REMLIFE Trading & Distributors
Screen Remedium Lifecare share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price BSE
₹0.83
▼ -0.01 (-1.19%)
2026-01-07 00:00:00
Market Cap ₹66.13 Cr.
P/B Ratio 0.79
EPS (TTM) ₹0.05
Dividend Yield -
Debt to Equity 26.01
52W High ₹4.28
52W Low ₹0.70
Operating Margin -
Profit Margin -0.75%
Revenue (TTM) ₹265.00
EBITDA -
Net Income ₹-2.00
Total Assets ₹1,720.00
Total Equity ₹44.00

Remedium Lifecare Share Price History - Stock Screener Chart

Screen REMLIFE historical share price movements with interactive charts. Analyze price trends and patterns.

Remedium Lifecare Company Profile - Fundamental Screener

Screen Remedium Lifecare company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for REMLIFE shares.
Sector Commercial Services
Industry Trading & Distributors
Sub-Sector Trading & Distributors
Segment E
ISIN INE549S01036

Remedium Lifecare Balance Sheet Screener - Fundamental Analysis

Fair Value Analysis
Screen REMLIFE balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
Item 2025
Assets
Total Assets 1,720
Current Assets 1,720
Fixed Assets 0
Liabilities
Total Liabilities 1,720
Current Liabilities 0
Non-Current Liabilities 0
Shareholders' Equity
Total Equity 44
Share Capital 40
Reserves & Surplus 4
Screen REMLIFE income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
Item 2025-Mar 2025-Jun 2025-Sept
Revenue 265 117 114
Expenses 265 112 104
EBITDA 0 5 11
Operating Profit % 0.00% 2.00% 7.00%
Depreciation 0 0 0
Interest 2 0 0
Profit Before Tax -1 6 10
Tax 1 1 2
Net Profit -2 5 9
EPS -0.05 0.05 0.10

Remedium Lifecare Cash Flow Screener - Liquidity Fundamentals

Screen REMLIFE cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
Item 2025-March
Operating Activities -1,135
Investing Activities 0
Financing Activities 1,136
Net Cash Flow 1
Screen REMLIFE shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
Item 2025-Mar 2025-Jun 2025-Sept 2024-Mar 2024-Jun 2024-Jul 2024-Sept 2024-Dec
Promoter Holding 1.11% 1.13% 1.13% 1.11% 1.11% 1.11% 1.11% 1.11%
FII Holding 0.00% 0.00% 0.00% 0.04% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 87.29% 78.39% 79.02% 82.21% 83.33% 84.50% 85.01% 86.10%
Other Holding 11.60% 20.48% 19.85% 16.64% 15.56% 14.39% 13.87% 12.79%
Shareholder Count 110,422 113,543 114,119 15,587 26,464 41,565 67,404 73,637

Remedium Lifecare Dividend Screener - Share Yield Analysis

Screen REMLIFE dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
No dividends declared by Remedium Lifecare.

Remedium Lifecare Index Membership - Market Screener Classification

Screen REMLIFE by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Remedium Lifecare is not part of any tracked indices.
Only major market indices are tracked in our system.

Remedium Lifecare Market Events Screener - Corporate Actions

Screen REMLIFE market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
Announcement Date Record Date Event Type Information Price Impact
Annual General Meeting NA 13.64%
Change Of Name NA 0.00%
2023-06-23 Split 5:10 0.00%
2025-11-14 2025-11-14 Quarterly Result Announcement NA -14.47%
2025-08-04 2025-08-04 Quarterly Result Announcement NA 3.15%
2025-05-30 2025-05-30 Quarterly Result Announcement NA 2.82%
2025-04-15 2025-04-15 Rights 61:50 0.65%
2025-02-14 2025-02-14 Quarterly Result Announcement NA -7.14%
2024-11-14 2024-11-14 Quarterly Result Announcement NA -2.35%
2024-07-05 2024-07-06 Bonus 3:1 29.04%
2024-06-26 2024-06-26 Annual General Meeting NA -16.45%
2024-02-23 2024-01-08 Split 1:5 0.00%
2023-07-28 Bonus 9:5 -

Remedium Lifecare Competitors Screener - Peer Comparison

Screen REMLIFE competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Redington 21,292 11.02 99,562 11.11% 1,821 46.66
Elitecon International 15,953 61.72 551 55040.00% 70 42.53
MMTC 10,085 45.91 263 28.63% 87 65.64
MSTC 3,681 8.70 388 -25.38% 407 63.45
BN Agrochem 3,643 55.86 367 5071.83% 20 47.25
Ravindra Energy 2,837 41.25 262 79.10% 23 48.50
TCC Concept 2,329 47.96 90 14.72% 42 57.61
Vintage Coffee & Beverages 2,285 37.15 313 136.92% 40 48.56
Creative Newtech 1,091 18.05 1,802 3.48% 53 50.66
Polo Queen Industrial And Fintech 1,039 384.38 81 15.16% 3 37.32

Remedium Lifecare Company Announcements - News Screener

Screen REMLIFE latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
Date Update Actions
2025-12-29 Closure of Trading Window View
2025-12-15 Announcement under Regulation 30 (LODR)-Change of Company Name View
2025-12-08 Shareholder Meeting / Postal Ballot-Scrutinizer"s Report View
2025-12-08 Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot View
2025-11-17 Announcement under Regulation 30 (LODR)-Newspaper Publication View
2025-11-17 Announcement under Regulation 30 (LODR)-Press Release / Media Release View
2025-11-14 Results - Financial Results For Quarter And Half Year Ended September 30 2025 View
2025-11-14 Board Meeting Outcome for Board Meeting Outcome For The Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Half Year Ended September 30 2025 View
2025-11-10 Announcement under Regulation 30 (LODR)-Press Release / Media Release View
2025-11-06 Board Meeting Intimation for To Consider And Approve Unaudited Standalone And Consolidated Results For Quarter And Half Year Ended 30.09.2025 View
2025-11-06 Announcement under Regulation 30 (LODR)-Newspaper Publication View
2025-11-04 Shareholder Meeting / Postal Ballot-Notice of Postal Ballot View
2025-10-31 Appointment Of Mr. Rambhajan Vishwakarma And Mr. Vignesh Laxman Gawde View
2025-10-31 Board Meeting Outcome for Regulation 30 Of SEBI (Listing Obligation And Disclosure Requirements) Regulation 2015 For Outcome Of Board Meeting Held On Friday 31St October 2025 View
2025-10-29 Announcement under Regulation 30 (LODR)-Resignation of Director View
2025-10-10 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 View
2025-10-06 Announcement under Regulation 30 (LODR)-Resignation of Director View
2025-09-24 Shareholder Meeting / Postal Ballot-Scrutinizers Report View
2025-09-24 Shareholder Meeting / Postal Ballot-Outcome of AGM View
2025-09-23 Closure of Trading Window View